semaglutide gastrointestinal obstruction class action in kentucky gi Rybelsus Side Effect Lawsuits kentucky glp-1 gastric intestinal obstruction

A one-size-fits-all approach to weight loss rarely yields sustainable results

Ozempic and Zepbound are both medications designed to assist with weight loss

Breast Cancer: A 3047% Risk Reduction Among the most clinically significant findings was a real-world cohort study presented at ASCO 2026, which reported that women with Type 2 diabetes or obesity using GLP-1 receptor agonists experienced a 30 to 47% reduction in breast cancer risk compared to non-users

Moreover, the compound has shown promise in reducing cardiovascular risk, highlighting its potential as a versatile agent in metabolic health management

Youre not just losing weight, youre learning how to manage your hunger, cravings, and energy levels in a way that sticks long after you reach your goal